Toblerone: detecting exon deletion events in cancer using RNA-seq

Andrew Lonsdale1,2,3, Andreas Halman1,3, Lauren Brown2,4,5

  • 1Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, 3010, Australia.

F1000Research
|September 28, 2023
PubMed

Insights

This study introduces Toblerone, a novel method using RNA-seq to detect gene exon deletions, specifically applied to IKZF1 deletions in acute lymphoblastic leukemia (ALL) for improved patient outcome prediction.

Area of Science:

  • Genomics
  • Molecular Biology
  • Bioinformatics

Background:

  • Cancer arises from genomic mutations, including oncogene activation and tumor suppressor gene repression.
  • IKZF1 gene deletions in acute lymphoblastic leukemia (ALL) correlate with poor patient prognosis and increased relapse rates.
  • Accurate detection of IKZF1 deletions is crucial for informing ALL treatment strategies.

Purpose of the Study:

  • To develop and validate a method for detecting exon deletions in genes using RNA-sequencing (RNA-seq) data.
  • To apply this method to identify IKZF1 deletions in pediatric B-ALL samples.
  • To create a user-friendly application for non-bioinformaticians to analyze RNA-seq data for IKZF1 deletions.

Main Methods:

  • Developed a bioinformatics pipeline utilizing a custom transcriptome reference with known exon deletions.
  • Employed a pseudoalignment algorithm to map RNA-seq reads and identify those supporting deletions.
  • Integrated gene expression analysis and cohort-wide comparisons to validate deletion evidence.

Main Results:

  • Successfully applied the Toblerone algorithm to a cohort of 99 pediatric B-ALL samples.
  • Identified and validated IKZF1 deletions within the studied cohort.
  • Developed a graphical desktop application for accessible deletion analysis.

Conclusions:

  • The Toblerone method provides an effective means for detecting gene exon deletions from RNA-seq data.
  • This approach, particularly for IKZF1 deletions in ALL, can aid in prognostic assessment and treatment decisions.
  • The accompanying graphical application democratizes the analysis of RNA-seq data for clinical applications.
Keywords:
RNA-seqcancer